Company / Current Assets
ENDONOVO THERAPEUTICS, INC. Current Assets History
FY2011-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$15.8K
FY2022
5-year range
$15.8K / $382.5K
FY2018-FY2022
Trend
-83.3%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets has fluctuated over the past 9 years, ranging from $2,988 in FY2014 to $382,496 in FY2018.
Based on SEC 10-K filings.
$15,822 in FY2022 with a 3-year CAGR of -36.8%.
Declined from $46,187 to $15,822 over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- -36.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -36.8%, indicating a declining trend.
- In FY2022, current assets decreased 83.3% year-over-year.
- Peak current assets was recorded in FY2018.
- Lowest current assets in the period was in FY2014.
Company context
Key Data Points
- Altman Z-Score -76.54 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $15.8K | -83.3% |
| FY2021 | $94.9K | +105.4% |
| FY2020 | $46.2K | -26.2% |
| FY2019 | $62.6K | -83.6% |
| FY2018 | $382.5K | +26.3% |
| FY2016 | $302.9K | -19.8% |
| FY2015 | $377.7K | +12540.8% |
| FY2014 | $3.0K | -95.8% |
| FY2011 | $71.1K | - |
As of FY2022 · SEC 10-K · Updated Jun 29, 2026